Table 4 Assessment of responsiveness of the EQ-5D-3L and the EQ-5D-5L measures to changes in the Barthel Index (n = 224)
EQ-5D-3L at 6 months (mean) | EQ-5D-3L at 12 months (mean) | Difference between 12 and 6 months EQ-5D-3L (95% CI) | Effect size (Cohen’s D)a | n | % reporting 3L score increase | |
|---|---|---|---|---|---|---|
Barthel Index | ||||||
Improved | 0.68 | 0.83 | 0.16 (0.07 to 0.25) | 0.66** | 31 | 55 |
No change | 0.89 | 0.87 | − 0.02 (− 0.05 to 0.02) | − 0.09 | 142 | 25 |
Worsened | 0.74 | 0.66 | − 0.08 (− 0.16 to 0.00) | − 0.30* | 50 | 28 |
EQ-5D-5L at 6 months (mean) | EQ-5D-5L at 12 months (mean) | Difference between 12 and 6 months EQ-5D-5L (95% CI) | Effect size (Cohen’s D) | n | % reporting 5L score increase | |
|---|---|---|---|---|---|---|
Barthel Index | ||||||
Improved | 0.68 | 0.81 | 0.13 (0.07 to 0.20) | 0.66*** | 31 | 59 |
No change | 0.87 | 0.86 | − 0.01 (− 0.04 to 0.02) | − 0.05 | 142 | 32 |
Worsened | 0.73 | 0.65 | − 0.09 (− 0.14 to − 0.03) | − 0.36** | 50 | 32 |